Stock listing
Frankfurt:AXD2 Heron Therapeutics, Inc. Aktie
German listing (Frankfurt) of Heron Therapeutics, Inc. · home listing NASDAQ:HRTX
Follow Heron Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · FWB:AXD2
€0.285 EUR -0.005 (-1.6%)
Close on Nov 16, 2026
- Day range
- €0.285 – €0.285 EURNov 16, 2026
- Market cap
- €54.11M EURAt the close on Nov 16, 2026 · price × 189.9M shares outstanding
- 52-week range
- €0.245 – €1.288 EURLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
- Traded on an average day
- €456 EURMedian day 0 shares · 53 days with no trades · last 3 months, Aug 17, 2026 – Nov 12, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HRTX · Home | $0.284 USD | -0.026 (-8.4%) | 5,907,252 | $0.303 | $0.330 | $0.268 | $0.311 | Close on Nov 16, 2026 |
| LSE:0J4V | $0.302 USD | -0.047 (-13.4%) | 19,975 | $0.320 | $0.330 | $0.300 | $0.349 | Close on Nov 16, 2026 |
| Frankfurt:AXD2 | €0.285 EUR | -0.005 (-1.6%) | — | €0.285 | €0.285 | €0.285 | €0.290 | Close on Nov 16, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 12, 2026 · FWB:AXD2 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.318 | -0.015 | -4.5% | €0.318 | €0.318 | €0.318 | 0 | |
| €0.333 | +0.006 | +1.8% | €0.333 | €0.333 | €0.333 | 3,000 | |
| €0.327 | +0.072 | +28.2% | €0.324 | €0.328 | €0.324 | 21,588 | |
| €0.255 | +0.009 | +3.7% | €0.255 | €0.255 | €0.255 | 0 | |
| €0.246 | -0.011 | -4.3% | €0.246 | €0.246 | €0.246 | 500 | |
| €0.257 | +0.008 | +3.2% | €0.257 | €0.257 | €0.257 | 5,314 | |
| €0.249 | -0.003 | -1.2% | €0.249 | €0.249 | €0.249 | 5,314 | |
| €0.252 | +0.007 | +2.9% | €0.256 | €0.258 | €0.250 | 0 | |
| €0.245 | -0.017 | -6.5% | €0.245 | €0.245 | €0.245 | 0 | |
| €0.262 | -0.010 | -3.7% | €0.262 | €0.262 | €0.262 | 0 | |
| €0.272 | +0.005 | +1.9% | €0.272 | €0.272 | €0.272 | 4,000 | |
| €0.267 | +0.003 | +1.1% | €0.267 | €0.267 | €0.267 | 4,694 | |
| €0.264 | -0.001 | -0.4% | €0.264 | €0.264 | €0.264 | 0 | |
| €0.265 | +0.006 | +2.3% | €0.265 | €0.265 | €0.265 | 0 | |
| €0.259 | -0.036 | -12.2% | €0.259 | €0.259 | €0.259 | 0 | |
| €0.295 | -0.018 | -5.8% | €0.295 | €0.295 | €0.295 | 0 | |
| €0.313 | -0.004 | -1.3% | €0.313 | €0.313 | €0.313 | 0 | |
| €0.317 | +0.001 | +0.3% | €0.317 | €0.317 | €0.317 | 0 | |
| €0.316 | -0.014 | -4.2% | €0.316 | €0.316 | €0.316 | 0 | |
| €0.330 | +0.013 | +4.1% | €0.330 | €0.330 | €0.330 | 0 | |
| €0.317 | -0.025 | -7.3% | €0.317 | €0.317 | €0.317 | 0 | |
| €0.342 | -0.020 | -5.5% | €0.342 | €0.342 | €0.342 | 0 | |
| €0.362 | +0.001 | +0.3% | €0.362 | €0.362 | €0.362 | 0 | |
| €0.361 | +0.041 | +12.8% | €0.361 | €0.361 | €0.361 | 0 | |
| €0.320 | -0.014 | -4.2% | €0.320 | €0.320 | €0.320 | 36,000 | |
| €0.334 | +0.037 | +12.5% | €0.334 | €0.334 | €0.334 | 0 | |
| €0.297 | -0.027 | -8.3% | €0.297 | €0.297 | €0.297 | 0 | |
| €0.324 | +0.019 | +6.2% | €0.324 | €0.324 | €0.324 | 0 | |
| €0.305 | -0.011 | -3.5% | €0.305 | €0.305 | €0.305 | 0 | |
| €0.316 | +0.038 | +13.7% | €0.309 | €0.320 | €0.306 | 12,770 | |
| €0.278 | +0.008 | +3.0% | €0.278 | €0.278 | €0.278 | 0 | |
| €0.270 | +0.019 | +7.6% | €0.270 | €0.270 | €0.270 | 0 | |
| €0.251 | -0.002 | -0.8% | €0.251 | €0.251 | €0.251 | 0 | |
| €0.253 | +0.001 | +0.4% | €0.253 | €0.253 | €0.253 | 0 | |
| €0.252 | +0.001 | +0.4% | €0.252 | €0.252 | €0.252 | 0 | |
| €0.251 | -0.008 | -3.1% | €0.251 | €0.251 | €0.251 | 0 | |
| €0.259 | +0.013 | +5.3% | €0.259 | €0.259 | €0.259 | 0 | |
| €0.246 | -0.020 | -7.5% | €0.246 | €0.246 | €0.246 | 0 | |
| €0.266 | -0.008 | -2.9% | €0.266 | €0.266 | €0.266 | 0 | |
| €0.274 | +0.001 | +0.4% | €0.274 | €0.274 | €0.274 | 0 | |
| €0.273 | +0.008 | +3.0% | €0.273 | €0.273 | €0.273 | 0 | |
| €0.265 | -0.003 | -1.1% | €0.265 | €0.265 | €0.265 | 0 | |
| €0.268 | -0.006 | -2.2% | €0.268 | €0.268 | €0.268 | 0 | |
| €0.274 | +0.001 | +0.4% | €0.274 | €0.274 | €0.274 | 0 | |
| €0.273 | -0.012 | -4.2% | €0.273 | €0.273 | €0.273 | 0 | |
| €0.285 | -0.013 | -4.4% | €0.285 | €0.285 | €0.285 | 0 | |
| €0.298 | +0.007 | +2.4% | €0.298 | €0.298 | €0.298 | 0 | |
| €0.291 | -0.001 | -0.3% | €0.291 | €0.291 | €0.291 | 0 | |
| €0.292 | +0.012 | +4.3% | €0.292 | €0.292 | €0.292 | 0 | |
| €0.280 | +0.009 | +3.3% | €0.280 | €0.280 | €0.280 | 0 | |
| €0.271 | +0.004 | +1.5% | €0.271 | €0.271 | €0.271 | 0 | |
| €0.267 | -0.007 | -2.6% | €0.267 | €0.267 | €0.267 | 0 | |
| €0.274 | -0.009 | -3.2% | €0.274 | €0.274 | €0.274 | 0 | |
| €0.283 | +0.004 | +1.4% | €0.279 | €0.284 | €0.277 | 400 | |
| €0.279 | +0.010 | +3.7% | €0.279 | €0.279 | €0.279 | 1,000 | |
| €0.269 | -0.002 | -0.7% | €0.269 | €0.269 | €0.269 | 0 | |
| €0.271 | +0.001 | +0.4% | €0.271 | €0.271 | €0.271 | 0 | |
| €0.270 | -0.001 | -0.4% | €0.270 | €0.270 | €0.270 | 0 | |
| €0.271 | +0.010 | +3.8% | €0.271 | €0.271 | €0.271 | 0 | |
| €0.261 | -0.005 | -1.9% | €0.261 | €0.261 | €0.261 | 0 | |
| €0.266 | +0.003 | +1.1% | €0.266 | €0.266 | €0.266 | 0 | |
| €0.263 | -0.012 | -4.4% | €0.263 | €0.263 | €0.263 | 0 | |
| €0.275 | -0.015 | -5.2% | €0.275 | €0.275 | €0.275 | 0 | |
| €0.290 | +0.003 | +1.0% | €0.290 | €0.290 | €0.290 | 0 |
Splits
1 split · FWB:AXD2 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-20 | Consolidation |
- Ticker
- Frankfurt:AXD2
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 9, 2026
Heron Therapeutics Announces Third Quarter 2026 Financial Results
Latest earnings call · Aug 10, 2026
Heron Therapeutics (NASDAQ:HRTX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · May 11, 2026
Q1 2026 Earnings Presentation
Earnings · 23 slides
Calls
Replays
Heron Therapeutics (NASDAQ:HRTX) Q2 2026 Earnings Call
Mon, Aug 10, 2026 · 8:30 AM ET
Watch TranscriptHeron Therapeutics (NASDAQ:HRTX) Q1 2026 Earnings Call
Mon, May 11, 2026 · 8:30 AM ET
Watch TranscriptHeron Therapeutics (NASDAQ:HRTX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Heron Therapeutics Announces Third Quarter 2026 Financial Results
Nov 9, 2026
Closed €0.255 (+3.7%) on Nov 9, 2026
CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care
Nov 9, 2026
Closed €0.255 (+3.7%) on Nov 9, 2026
Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
Oct 26, 2026
Closed €0.264 (-0.4%) on Oct 27, 2026
Heron Therapeutics Announces Second Quarter 2026 Financial Results
Aug 10, 2026
Closed €0.431 (+3.1%) on Aug 10, 2026
Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026
Jul 27, 2026
Closed €0.393 (-1.3%) on Jul 27, 2026
U.S. District Court Issues Decision Regarding CINVANTI® Patents
Jun 2, 2026
Closed €0.439 (-40.7%) on Jun 2, 2026
Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance
May 11, 2026
Closed €1.05 (+0.2%) on May 11, 2026
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026
Apr 27, 2026
Closed €1.01 (+1.3%) on Apr 28, 2026
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
Feb 26, 2026
Closed €0.897 (-1.0%) on Feb 26, 2026
Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
Feb 17, 2026
Closed €0.959 (-0.6%) on Feb 17, 2026
Financings
5.0% senior convertible notes due 2031
Aug 8, 2025
Announced: US$35M · Leerink Partners
Dealers: Leerink Partners
Use of proceeds: Retire prior convertible notes and the working capital facility, and provide working capital for commercial and development initiatives
Private placement of common and preferred equity
Aug 8, 2025
Announced: US$27.7M · Leerink Partners
Dealers: Leerink Partners (lead)
Use of proceeds: Retire prior convertible notes and the working capital facility, and provide working capital for commercial and development initiatives
Decks
Q1 2026 Earnings Presentation
Earnings · 23 slides · May 11, 2026
Q4 2025 Earnings Presentation
Earnings · 15 slides · Feb 26, 2026
Q2 2025 Earnings Presentation
Earnings · 16 slides · Aug 11, 2025
Q1 2025 Earnings Presentation
Earnings · 15 slides · May 6, 2025
Heron Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 12 in the last 12 months · 146 in all · newest Nov 9, 2026 · oldest 2019
- Calls
- 20 calls with a replay · 20 with a transcript · latest Aug 10, 2026
- Decks
- 62 decks · latest May 11, 2026
Where Heron Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HRTX · Home listing | NASDAQ | United States | USD |
| BOATS:HRTX | BOATS | United States | USD |
| Lang & Schwarz:A1XB6K | Lang & Schwarz | Germany | EUR |
| LS Exchange:A1XB6K | LS Exchange | Germany | EUR |
| LSE:0J4V | LSE | United Kingdom | USD |
| Stuttgart:AXD2 | Stuttgart | Germany | EUR |
| gettex:AXD2 | gettex | Germany | EUR |
| Dusseldorf:AXD2 | Dusseldorf | Germany | EUR |
| Frankfurt:AXD2 · This page | Frankfurt | Germany | EUR |
| Tradegate:AXD2 | Tradegate | Germany | EUR |
| BX Swiss:AXD2 | BX Swiss | Switzerland | CHF |
| Munich:AXD2 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Heron Therapeutics, Inc.